Maria Soloveychik is the CEO and co-founder of SyntheX Labs, a biotech company developing peptide therapeutics for cancer and other rare diseases. SyntheX labs was part of IndieBio batch #3 in 2016. They have successfully raised seed capital to move their vision forward.
Maria Soloveychik and Charly Chahwan are working on curing untreatable cancer. They are disrupting the drug discovery cycle which typically takes $10m to $15m and upto 6 years. They have created compounds that have similar efficacy as other drugs and they were able to get to that stage in 2 months at the cost of $20,000. If that is not disruptive I am not sure what is.